P42 | Efficacy and safety of roxadustat in patients with non-dialysis-dependent chronic kidney disease with or without inflammation: pooled analysis of four phase 3 studies: G. Choukroun1, A. Harkavyi2, V. Santos3, A. Jiletcovici3, L. Del Vecchio4 | 1CHU Amiens Picardie and Jules Verne University, Amiens, France, 2Astellas Pharma Europe, Addlestone, UK, 3Astellas Pharma, Inc., Northbrook, USA, 4Sant’Anna Hospital, Como, Italy. Italian Journal of Medicine, [S. l.], v. 19, n. 1(s1), 2025. DOI: 10.4081/itjm.2025.2234. Disponível em: https://www.italjmed.org/ijm/article/view/2234. Acesso em: 2 sep. 2025.